---
layout: minimal-medicine
title: Meglumine Antimoniate
---

# Meglumine Antimoniate
### Generic Name
Meglumine Antimoniate

### Usage
Meglumine antimoniate is primarily used to treat leishmaniasis, a disease caused by infection with *Leishmania* parasites.  This parasitic infection can manifest in various forms, including cutaneous (skin), mucocutaneous (skin and mucous membranes), and visceral (internal organs) leishmaniasis.  Meglumine antimoniate is particularly effective against visceral leishmaniasis, a severe and potentially fatal form of the disease. While it's primarily used for leishmaniasis, there are no notable secondary uses currently established.

### Dosage
Dosage of meglumine antimoniate is typically determined by the patient's weight and the severity of the leishmaniasis.  The information provided here is for guidance only, and a healthcare professional should always be consulted for precise dosing instructions.

* **Adults and Children (Leishmaniasis):** The usual intramuscular (IM) dose is 20 mg/kg of pentavalent antimony (the active component) per day for 20–28 days.  In cases of mild cutaneous leishmaniasis, the injection might be administered directly into the skin lesion.  The duration and repetition of treatment may vary depending on individual patient response and disease severity.

**Important Note:** There is no specific pediatric dosage different from the adult dosage mentioned. However, careful monitoring of children receiving this medication is crucial.  Adjustments may be needed based on the child's age, weight, and overall health.

**Dosage Adjustments:** Meglumine antimoniate is contraindicated in individuals with hepatic (liver) or renal (kidney) impairment, meaning it should not be used in these cases.

### Side Effects
Common side effects of meglumine antimoniate can include:

* Headache
* Malaise (general discomfort)
* Dyspnea (shortness of breath)
* Skin rashes
* Facial edema (swelling)
* Abdominal pain

Less common, but potentially serious side effects may include changes in electrocardiogram (ECG) readings,  hepatic or renal impairment. It is vital to report any side effects, particularly those listed above, immediately to a healthcare provider.


### How it Works
The precise mechanism by which meglumine antimoniate kills *Leishmania* parasites is not fully understood. However, it's known to interfere with the parasite's energy production and antioxidant defense mechanisms. By inhibiting glycolysis (glucose metabolism) and fatty acid oxidation, meglumine antimoniate reduces the parasite's ability to generate energy (ATP) and protect itself from oxidative stress. This ultimately leads to the parasite's death.

### Precautions
* **Contraindications:** Meglumine antimoniate is contraindicated in patients with hepatic or renal impairment, heart disease, or pancreatic disease.
* **Drug Interactions:**  Concomitant use of meglumine antimoniate with antiarrhythmic drugs should be avoided due to the increased risk of cardiac adverse effects.
* **Pregnancy and Breastfeeding:** The safety of meglumine antimoniate during pregnancy has not been fully established.  However, the risk of untreated visceral leishmaniasis, which is potentially fatal, must be weighed against the potential risks of the medication.  The excretion of meglumine antimoniate in breast milk is unknown, but it's considered compatible with breastfeeding according to the World Health Organization (WHO, 2002).


### FAQs

* **Q: How is meglumine antimoniate administered?** A: Typically administered via intramuscular injection. For mild cutaneous leishmaniasis, it may be injected directly into the skin lesion.
* **Q: How long does treatment usually last?** A:  Treatment typically lasts for 20-28 days, but this can vary depending on the patient's response and disease severity.
* **Q: What should I do if I experience side effects?** A: Report any side effects, especially serious ones, to your healthcare provider immediately.
* **Q: Can I take meglumine antimoniate with other medications?** A: Consult your doctor about any other medications you are taking to avoid potential interactions. Particularly avoid concurrent use with antiarrhythmic drugs.
* **Q: How should I store meglumine antimoniate?** A: Follow your pharmacist’s or doctor's storage instructions carefully.  Generally, medications should be stored as directed on the label.
* **Q: Is meglumine antimoniate safe for everyone?** A: No.  It's contraindicated in individuals with liver or kidney problems, heart disease, or pancreatic disease.  Always consult your healthcare provider before taking this medication.


**Disclaimer:** This information is intended for general knowledge and informational purposes only, and does not constitute medical advice.  Always consult a healthcare professional for any health concerns or before making any decisions related to your health or treatment.
